COVID-19 in Immunocompromised Patients: Is Prevention Better Than Cure? – A Podcast Series
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.
Click Here to Manage Email Alerts
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.
Activity Description
COVID-19 still poses considerable morbidity and mortality risk for vulnerable populations. Immunocompromised individuals are at increased risk for breakthrough SARS-CoV-2 infection, high symptomatic burden, and progression to severe COVID-19. Additionally, immune suppression due to certain medical conditions or therapies may limit the ability to mount a sufficient immune response with vaccination. Disease prevention is therefore of great importance for this patient population. In this podcast series, faculty in immunology and infectious diseases discuss current challenges and opportunities regarding COVID-19 prevention and management in immunocompromised individuals. Experts will summarize strategies to educate patients and practitioners on the outpatient management of COVID-19 in this vulnerable group.
Target Audience
The intended audience for the activity is pulmonologists, hospitalists, critical care physicians, intensivists, rheumatologists, immunologists, infectious disease specialists, and other health care professionals involved in the management of patients with or at risk for COVID-19.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Describe the rationale for the use of COVID-19 preexposure prophylaxis (PrEP) therapy in immunocompromised patients including the latest clinical evidence on its safety and efficacy.
- Identify patients who may benefit from COVID-19 PrEP therapy.
- Summarize strategies to educate patients and practitioners on the outpatient management of COVID-19 in immunocompromised patients.
Activity Chair
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, OH
Faculty
Cassandra Calabrese, DO
Assistant Professor of Medicine
Rheumatology and Infectious Disease
Cleveland Clinic Foundation
Cleveland, OH
Myron Cohen, MD
Yeargan-Bate Professor of Medicine, Microbiology and Epidemiology
Associate Vice Chancellor for Medical Affairs Global Health Director, Institute for Global Health and Infectious Diseases
UNC School of Medicine
Division of Infectious Disease
Chapel Hill, NC
Alfred Kim, MD, PhD
Associate Professor, Medicine
Associate Professor, Pathology & Immunology
Director, Lupus Center
Washington University School of Medicine
St. Louis, MO
Kevin L. Winthrop, MD, MPH
Professor, Division of Infectious Diseases
Schools of Medicine and Public Health
Oregon Health and Sciences University
Portland, OR
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, September 25, 2023, to December 15, 2023.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, listen to the podcasts, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Myron Cohen, MD
Advisor: AstraZeneca, GSK
Consultant: Atea, Aerium
Cassandra Calabrese, DO
Consultant: AstraZeneca, Lilly
Leonard H. Calabrese, DO
Consultant: GSK
Speaker Contracted by Ineligible Company: AstraZeneca
Alfred Kim, MD, PhD
Consultant: AstraZeneca, GSK, Pfizer
Speaker Contracted by Ineligible Company: GSK
Independent Research Contractor: GSK
Kevin L. Winthrop, MD, MPH
Consultant: AbbVie, AstraZeneca, Gilead, GSK, Pfizer, Regeneron, Roche
Independent Research Contractor: Pfizer
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com